Shaun Png

Dr. Shaun Png

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2020 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
MSMartijn J. Schuijs
Martijn J. Schuijs
SPShaun Png
Shaun Png
ARArianne C. Richard
Arianne C. Richard
ATAnastasia Tsyben
Anastasia Tsyben
GHGregory Hamm
Gregory Hamm
THTimotheus You Fu Halim
Timotheus You Fu Halim

19 July 2024 in Science Immunology
Verified
Journal Article
Closed access
JSJulie Stockis
Julie Stockis
TYThomas Yip
Thomas Yip
JMJulia Moreno-Vicente
Julia Moreno-Vicente
OBOliver Burton
Oliver Burton
YSYouhani Samarakoon
Youhani Samarakoon
THTimotheus You Fu Halim
Timotheus You Fu Halim
Regulatory T cells (T regs ) control adaptive immunity and restrain type 2 inflammation in allergic disease. Interleukin-33 promotes the expansion of tissue-resident T regs and group 2 innate lymphoid cells (ILC2s); however, how T regs locally coordinate their function within the inflammatory niche is not understood. Here, we show that ILC2s are critical orchestrators of T reg function. Using spatial, cellular, and molecular profiling of the type 2 inflamed niche, we found that ILC2s and T regs engage in a direct (OX40L-OX40) and chemotaxis-dependent (CCL1-CCR8) cellular dialogue that enforces the local accumulation of Gata3 high T regs , which are transcriptionally and functionally adapted to the type 2 environment. Genetic interruption of ILC2-T reg communication resulted in uncontrolled type 2 lung inflammation after allergen exposure. Mechanistically, we found that Gata3 high T regs can modulate the local bioavailability of the costimulatory molecule OX40L, which subsequently controlled effector memory T helper 2 cell numbers. Hence, ILC2-T reg interactions represent a critical feedback mechanism to control adaptive type 2 immunity.

30 November 2025 in Cancers
Verified
Journal Article
Open access
PDF file
SPShaun Png
Shaun Png
Sirimuvva TadepalliSirimuvva Tadepalli
Sirimuvva Tadepalli
Edward Elliot GravesEdward Elliot Graves
Edward Elliot Graves
Radiotherapy remains a central component of cancer therapy that induces DNA damage and cancer cell death. Beyond its cytotoxic effects, radiotherapy acts as a potent immunomodulator by releasing immunogenic molecules, inflammatory mediators, and neoantigens that shape anti-tumor immunity. Radiation-induced immune responses can have opposing effects, including immune activation or immunosuppression that dictate local tumor responses. Increasing evidence suggests these immunologic effects are not confined to the site of irradiation, as radiation exposure to surrounding normal tissue can trigger systemic immune signaling that affects local tumor progression as well as metastatic spread. This review examines radiotherapy-induced immune responses across three interconnected contexts: (i) tumor-intrinsic signaling during radiation; (ii) tumor microenvironmental changes where innate and adaptive immune responses alter local outcomes; and (iii) systemic and off-target effects contributing to broader immune remodeling. A comprehensive understanding of radiotherapy-induced immune responses will guide therapeutic strategies to enhance its immunological potential while minimizing unintended immune and off-target effects.